P. del Cerro

Methodological and logistical considerations to study design and data collection in racial/ethnic minority populations evaluating outcome disparity in hematopoietic cell transplantation.

K. van Besien, Stephanie J. Lee, S. Giralt, 2009, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Fludarabine, melphalan, and alemtuzumab conditioning in adults with standard-risk advanced acute myeloid leukemia and myelodysplastic syndrome.

T. Zimmerman, R. Larson, Dingcai Cao, 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Phase I study of dose-escalated busulfan with fludarabine and alemtuzumab as conditioning for allogeneic hematopoietic stem cell transplant: reduced clearance at high doses and occurrence of late sinusoidal obstruction syndrome/veno-occlusive disease

R. Larson, F. Innocenti, P. O’Donnell, 2010, Leukemia & lymphoma.

Reduced-intensity conditioning with combined haploidentical and cord blood transplantation results in rapid engraftment, low GVHD, and durable remissions.

R. Larson, J. Cunningham, W. Stock, 2011, Blood.

Phase I-II study of clofarabine-melphalan-alemtuzumab conditioning for allogeneic hematopoietic cell transplantation.

R. Larson, P. O’Donnell, W. Stock, 2012, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.